【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Liver Cancer Overview 7
3 Products under Development 8
3.1 Liver Cancer – Pipeline Products by Stage of Development 8
3.2 Liver Cancer – Pipeline Products by Territory 9
3.3 Liver Cancer – Pipeline Products by Regulatory Path 10
3.4 Liver Cancer – Pipeline Products by Estimated Approval Date 11
4 Liver Cancer – Pipeline Products under Development by Companies 12
4.1 Liver Cancer Companies – Pipeline Products by Stage of Development 12
4.2 Liver Cancer – Pipeline Products by Stage of Development 14
5 Liver Cancer Companies and Product Overview 16
5.1 Abbott Diagnostics Company Overview 16
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Almac Diagnostics Limited Company Overview 23
5.2.1 Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 AXO Science S.A.S. Company Overview 24
5.3.1 AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 BioMark Technologies Inc. Company Overview 28
5.4.1 BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.5 China Sky One Medical, Inc. Company Overview 29
5.5.1 China Sky One Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 Digna Biotech, S.L. Company Overview 30
5.6.1 Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Drexel University Company Overview 32
5.7.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 German Cancer Research Center Company Overview 35
5.8.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 35
5.9 Glycotest, Inc. Company Overview 36
5.9.1 Glycotest, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Imperial College London Company Overview 37
5.10.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 37
5.11 IntegraGen SA Company Overview 38
5.11.1 IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview 38
5.12 Matrix-Bio, Inc. Company Overview 40
5.12.1 Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.13 NanoString Technologies, Inc. Company Overview 42
5.13.1 NanoString Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.14 National Cancer Institute Company Overview 44
5.14.1 National Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview 44
5.15 Orion Genomics LLC Company Overview 47
5.15.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 PleX Diagnostics Company Overview 49
5.16.1 PleX Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 49
5.17 ProMIS Neurosciences Inc. Company Overview 50
5.17.1 ProMIS Neurosciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.18 Proplex Technologies, Llc Company Overview 52
5.18.1 Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview 52
5.19 Proteome Sciences Plc Company Overview 54
5.19.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 54
5.20 Roche Diagnostics International Ltd. Company Overview 56
5.20.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56
5.21 TrovaGene, Inc. Company Overview 58
5.21.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.22 University of Chicago Company Overview 60
5.22.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 60
5.23 University of Rochester Company Overview 62
5.23.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 62
5.24 Viomics Inc. Company Overview 63
5.24.1 Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.25 XEPTAGEN SpA Company Overview 64
5.25.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 64
5.26 Xiamen Zeesan Biotech Co.,Ltd Company Overview 71
5.26.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
6 Liver Cancer- Recent Developments 72
7 Appendix 73
7.1 Methodology 73
7.2 About GlobalData 75
7.3 Contact Us 76
7.4 Disclaimer 76
【レポート販売概要】
■ タイトル:世界における肝臓癌検査製品のパイプライン動向2015■ 英文:Liver Cancer - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0070EPD
■ 調査対象地域:グローバル
- 交通インフラの世界市場2017-2021:鉄道インフラ、都市公共交通機関インフラ、空港インフラ、道路・橋インフラ、港インフラABSTRACTAbout Transportation Infrastructure Transport is a critical driver of social and economic development, generating opportunities for the poor and facilitating economies to become more competitive. Transportation infrastructure connects individuals to jobs, health services, and education. Transportation infrastructure facilitates the supply of goods and services around the globe. For instanc …
- クラスDオーディオアンプの世界市場予測(~2024年)“Class D audio amplifier market to grow at CAGR of 9.5% from 2019 to 2024” The class D audio amplifier market is expected to grow from USD 2.3 billion in 2019 to USD 3.6 billion by 2024 at a CAGR of 9.5%. The growth of this market can be attributed to the increasing demand for consumer electronics and smart home devices, increasing traction toward in-vehicle infotainment systems in automobiles, an …
- 世界のバイク用ホーン市場2015The Global Motorcycle Horn Industry Report 2015 is a professional and in-depth study on the current state of the Motorcycle Horn industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Motorcycle Horn market analysis is provided for the international markets including development trends, competitive lands …
- 食品用酵素の世界市場:カルボヒドラーゼ、プロテアーゼ、リパーゼAbout Enzymes Enzymes are complex proteins that help accelerate reactions and catalyze biochemical reactions. They increase the reaction rates by lowering the activation energy of the reactants. Small quantities of enzymes are enough to increase the reaction rates up to a million times on account of their specific mode of action. Most of the enzymes are found to function in a narrow set of conditi …
- クラウドソリューション及び市場機会:Cloud Solutions and Market OpportunitiesThis report bundle represents the most comprehensive research covering the market for Cloud solutions and market opportunities. It includes research that addresses competitive analysis, market opportunities in various industry verticals, cloud applications and solutions, the future of the Cloud, and more. Key Cloud Impact Areas covered includes: ■ Cloud and Commerce, Content, and Applications ■ Cl …
- ネオンガスの世界市場2015-2019About neon gas Neon, a noble gas, is a chemical element that is found to exhibit chemical inertness on account of its unique atomic structure. This highly unreactive gas has a wide range of usage in non-reactive applications. Neon, although abundant in the universe, is sparse in earths atmosphere and is often produced through fractional distillation of liquefied air. The gas has superior refrigera …
- 世界のコンポジット市場動向(2012-2016)TechNavio’s analysts forecast the Global Composite market to reach US$28.34 billion by 2016. One of the key factors contributing to this market growth is the increasing demand from developing countries. The Global Composite market has also been witnessing developing strategic alliances and partnerships. However, the increasing price war among the competitors could pose a challenge to the growth of …
- tert-ブチル化リン酸トリフェニルの世界市場予測(~2026):用途別(潤滑剤、作動液、難燃剤)、地域別“Butylated triphenyl phosphate market is projected to reach USD 30.7 million by 2026”The global butylated triphenyl phosphate market is projected to reach USD 30.7 million by 2026, at a CAGR of 4.8% from 2016 to 2026. The increasing number of vehicles around the world has led to an increase in the demand for lubricants, which is in turn is driving the global butylated triphenyl phosphate market. W …
- 世界の高度エネルギー貯蔵システム市場動向と予測Electricity demand is expected to grow globally in the future by many folds. It is expected to grow to 32,000 TWh by 2035, a 70% increase from 2012. The global consumption of electricity is expected to grow by over 60% from 2011 to 2030. This huge demand increase has to be met by increased generation which requires 6,000 GW of added new capacity, apart from the existing capacity. The bulk of requi …
- Yervoy (Non-Small Cell Lung Cancer):市場予測と分析(~2022)Yervoy (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment lands …
- ベーカリーの世界市場:パン、ケーキ、ペーストリー、ビスケット、朝食用シリアルAbout Bakery Products Bakery products are popular worldwide. Breads and biscuits are the most consumed products, but demand for other bakery items such as cakes, pastries, and cookies is also increasing. The demand for traditional bakery product has deteriorated in the matured markets of Americas, and bakery manufacturers are expanding and experimenting with innovations in products such as whole w …
- ふっ素樹脂塗料の世界市場:PVDF、PTFE、FEP、ETFEThe properties of fluoropolymer coatings vary with the type of fluoropolymer resins used in formulation; however each coating displays the basic properties of fluoropolymers that is non-stick, anti-friction, wear and abrasion resistance and good dielectric and insulating properties. The various types of resins used in formulating fluoropolymer coating are PTFE, PVDF, FEP, ETFE, PFE, FEVE, ECTFE, e …
- バイオ殺線虫剤の世界市場:微生物、バイオ化学品The global bionematicides market has grown steadily in the last few years. The market size is projected to reach USD 337.2 Million by 2021, at a CAGR of around 17.4% from 2016 to 2021. Sustainability environmental initiatives along with the adoption of biologicals, the increasing growth of the biological control seed treatment solutions, and the utilization of integrated pest management techniques …
- カスタム抗体の世界市場予測(~2023年)“The global custom antibody market is projected to grow at a CAGR of 8.9%.”The custom antibody market is expected to reach USD 481 million by 2023 from an estimated USD 313 million in 2018, at a CAGR of 8.9%. Increase in research activities (especially in the life sciences industry), growing industry-academia collaborations, and the expanding antibody therapeutics pipeline are the primary growth d …
- デジタル資産管理の世界市場分析:タイプ別(ソリューション、サービス)、展開別(オンプレミス、クラウド)、用途別(セールス、マーケティング、IT)、エンドユーザー別(BFSI、小売、ヘルスケア)、セグメント予測、2014-2025The global digital asset management market is expected to reach USD 5.60 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to witness a healthy growth, ascribed to the increasing preference by organizations for rich media content for promoting brands and products. Further, the rising adoption of portable devices in enterprises has increased security …